Cargando…

Molecular classification of tissue from a transformed non-Hogkin’s lymphoma case with unexpected long-time remission

BACKGROUND: The concept of precision medicine in cancer includes individual molecular studies to predict clinical outcomes. In the present N = 1 case we retrospectively have analysed lymphoma tissue by exome sequencing and global gene expression in a patient with unexpected long-term remission follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bødker, Julie Støve, Severinsen, Marianne Tang, El-Galaly, Tarec Christoffer, Brøndum, Rasmus Froberg, Laursen, Maria Bach, Falgreen, Steffen, Nyegaard, Mette, Schmitz, Alexander, Jakobsen, Lasse Hjort, Schönherz, Anna Amanda, Due, Hanne, Reinholdt, Linn, Bøgsted, Martin, Dybkær, Karen, Johnsen, Hans Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225590/ https://www.ncbi.nlm.nih.gov/pubmed/28097046 http://dx.doi.org/10.1186/s40164-016-0063-0

Ejemplares similares

Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact
por: Schönherz, Anna A., et al.
Publicado: (2020)

hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine
por: Falgreen, Steffen, et al.
Publicado: (2016)

Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
por: Vesteghem, Charles, et al.
Publicado: (2019)

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
por: Reinholdt, Linn, et al.
Publicado: (2016)

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients
por: Laursen, Maria Bach, et al.
Publicado: (2019)

miR-155 as a Biomarker in B-Cell Malignancies
por: Due, Hanne, et al.
Publicado: (2016)

The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
por: Nesic, Marijana, et al.
Publicado: (2021)

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition
por: Falgreen, Steffen, et al.
Publicado: (2014)

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index
por: Due, Hanne, et al.
Publicado: (2020)

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
por: Falgreen, Steffen, et al.
Publicado: (2015)

Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow – A proof of concept study
por: Nørgaard, Caroline Holm, et al.
Publicado: (2018)

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
por: Jensen, Paw, et al.
Publicado: (2022)

A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
por: Issa, Issa Ismail, et al.
Publicado: (2021)

Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor
por: Rodrigo-Domingo, Maria, et al.
Publicado: (2014)

MicroRNAs in B-cells: from normal differentiation to treatment of malignancies
por: Marques, Sara Correia, et al.
Publicado: (2014)

Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region
por: Sommer, Mia, et al.
Publicado: (2020)

Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
por: Sommer, Mia, et al.
Publicado: (2021)

Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
por: Bødker, Julie S., et al.
Publicado: (2020)

A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells
por: Kloster, Maria Bro, et al.
Publicado: (2012)

Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis
por: Jespersen, Ditte Starberg, et al.
Publicado: (2019)

On estimating the time to statistical cure
por: Jakobsen, Lasse H., et al.
Publicado: (2020)

Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates
por: Bilgrau, Anders E., et al.
Publicado: (2016)

PB2706: NO DIFFERENCE IN SURVIVAL OUTCOMES BETWEEN IMMIGRANTS AND DANISH-BORN CITIZENS WITH A HEMATOLOGICAL MALIGNANCY: A NATIONWIDE, POPULATION-BASED REGISTER STUDY
por: Baech, Joachim, et al.
Publicado: (2023)

Regression on imperfect class labels derived by unsupervised clustering
por: Brøndum, Rasmus Froberg, et al.
Publicado: (2020)

Estimating the loss of lifetime function using flexible parametric relative survival models
por: Jakobsen, Lasse H., et al.
Publicado: (2019)

Long Noncoding RNA Expression during Human B-Cell Development
por: Petri, Andreas, et al.
Publicado: (2015)

Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study
por: Kristensen, Daniel Tuyet, et al.
Publicado: (2022)

Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients
por: Øvlisen, Andreas K., et al.
Publicado: (2020)

Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man
por: Bergkvist, Kim Steve, et al.
Publicado: (2014)

Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction
por: Schiøler, Henrik, et al.
Publicado: (2021)

Author Correction: Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction
por: Schiøler, Henrik, et al.
Publicado: (2022)

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
por: Joelsson, Joel, et al.
Publicado: (2022)

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
por: Tuyet Kristensen, Daniel, et al.
Publicado: (2023)

Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa
por: Marcussen, Mette, et al.
Publicado: (2017)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
por: Jensen, Oda, et al.
Publicado: (2022)

Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma
por: Marcussen, Mette, et al.
Publicado: (2018)

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022)

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
por: Schmitz, Alexander, et al.
Publicado: (2022)

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
por: El‐Galaly, Tarec Christoffer, et al.
Publicado: (2022)

High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019
por: Vesteghem, Charles, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ng3f2ssgj0kcr23i8qb2eofk37